Publicacions (19) Publicacions en què ha participat algun/a investigador/a

2024

  1. Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases

    Journal of Medicinal Chemistry, Vol. 67, Núm. 18, pp. 16533-16555

  2. Linking Myocardial Infarction and Frailty Status at Old Age in Europe: Moderation Effects of Country and Gender

    Journal of Cardiovascular Development and Disease, Vol. 11, Núm. 6

2023

  1. Disease-Modifying Effects of Vincamine Supplementation in Drosophila and Human Cell Models of Parkinson’s Disease Based on DJ-1 Deficiency

    ACS Chemical Neuroscience, Vol. 14, Núm. 12, pp. 2294-2301

  2. Evaluation of type 1 diabetes mellitus as a risk factor of Parkinson's disease in a Drosophila model

    Journal of Experimental Zoology Part A: Ecological and Integrative Physiology, Vol. 339, Núm. 8, pp. 697-705

  3. High Concentration of Protein Oxidation Biomarker O-Tyr/Phe Predicts Better Outcome in Childhood Bacterial Meningitis

    Antioxidants, Vol. 12, Núm. 3

  4. The Promotion of Mental Health and Prevention of First-Episode Psychosis: A Pilot and Feasibility Non-Randomised Clinical Trial

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 22

2022

  1. Antioxidant and Neuroprotective Effects of Carnosine: Therapeutic Implications in Neurodegenerative Diseases

    Antioxidants, Vol. 11, Núm. 5

  2. El problema psicosocial de la soledad en una muestra de personas mayores no institucionalizadas

    Ética de los cuidados: Humanización en salud, Núm. 15

  3. Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 36, Núm. 8, pp. e22432

  4. Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency

    Cells, Vol. 11, Núm. 3

  5. Modeling of Parkinson’s disease in Drosophila based on DJ-1 deficiency

    Handbook of Animal Models in Neurological Disorders (Elsevier), pp. 467-480

  6. Wellbeing Training Based on Contemplative Practices in a Sample of Intensive Care and Homecare Professionals: A Pilot and Feasibility Non-Randomized Clinical Trial

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 20

2021

  1. A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson’s Disease Treatment

    Neurotherapeutics, Vol. 18, Núm. 4, pp. 2565-2578

  2. Administration of iodinated contrast: What is the risk in cancer patients?

    European Journal of Cancer Care, Vol. 30, Núm. 1

  3. Evidencia de la valoración y tratamiento de la sepsis en el ámbito prehospitalario: revisión sistemática

    Enfermería integral: Revista científica del Colegio Oficial de Enfermería de Valencia, Núm. 128, pp. 55-62

  4. Neuromonitorización instrumentalizada no invasiva de la función cerebral: a propósito de un caso

    Enfermería integral: Revista científica del Colegio Oficial de Enfermería de Valencia, Núm. 129, pp. 46-51

  5. Oxidative modification impairs SERCA activity in Drosophila and human cell models of Parkinson's disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1867, Núm. 7

2020

  1. Enhanced activity of glycolytic enzymes in Drosophila and human cell models of Parkinson's disease based on DJ-1 deficiency

    Free Radical Biology and Medicine, Vol. 158, pp. 137-148

2019

  1. Drosophila as a model system for the identification of pharmacological therapies in neurodegenerative diseases

    Insights into Human Neurodegeneration: Lessons Learnt from Drosophila (Springer Singapore), pp. 433-467